Skip to main content

Table 1 Visual and quantitative parameters for disease states

From: Interpreting 123I–ioflupane dopamine transporter scans using hybrid scores

 

ET

(N = 34)

PD

(N = 85)

MA

(N = 6)

DLB

(N = 7)

ANOVA

F-ratio

Visual

0.81 ± 0.86

1.77 ± 0.55*

2.00 ± 0.00*

1.86 ± 0.38*

18.9

CSBR

2.08 ± 0.52

1.30 ± 0.54*

0.53 ± 0.23*†

0.80 ± 0.25*†

28.5

PSBR

1.24 ± 0.42

0.51 ± 0.36*

0.22 ± 0.17*†

0.28 ± 0.18*†

38.9

CAQ

5.34 ± 2.04

3.8 ± 1.76*

1.81 ± 1.39*†

1.94 ± 1.12*†

12.1

PAQ

2.11 ± 1.06

0.94 ± 0.61*

0.59 ± 0.49*

0.45 ± 0.40*†

23.8

Indexed Visual

0.18 ± 0.19

0.39 ± 0.13*

0.44 ± 0.02*

0.44 ± 0.09*†

17.2

Indexed CSBR

0.42 ± 0.11

0.25 ± 0.11*

0.10 ± 0.04*

0.16 ± 0.05*

29.7

Indexed PSBR

0.28 ± 0.09

0.11 ± 0.08*

0.05 ± 0.04*

0.07 ± 0.05*

41.2

Indexed CAQ

5.31 ± 1.09

3.67 ± 1.67*

1.74 ± 1.34*†

1.98 ± 1.11*†

13.2

Indexed PAQ

2.38 ± 1.27

1.02 ± 1.27*

0.64 ± 1.27*

0.53 ± 0.48*†

24.3

  1. ET essential tremor, PD Parkinson’s disease, MA multiple system atrophy, DLB dementia with Lewy bodies, ANOVA analysis of variance, C SBR caudate specific binding ratio, P SBR putamen specific binding ratio, CAQ minimum caudate absolute quantitative uptake, PAQ minimum putamen absolute quantitative uptake
  2. * p < 0.05 versus ET; † p < 0.05 versus PD